
According to latest reports from The Economic Times, Business Standard, CNBC TV18, Moneycontrol, NDTV Profit, and The Hindu BusinessLine, Honasa Consumer delivered exceptional Q1 FY27 results with consolidated net profit surging 119% year-on-year to ₹90.4 crore, compared with ₹41.3 crore in the corresponding quarter last year. The company achieved its highest-ever quarterly profit with PAT margin at 11%, while revenue hit a record ₹756 crore, up 27% year-on-year from ₹595 crore in Q1FY26. The company's EBITDA more than doubled to ₹110 crore from ₹46 crore a year ago, with EBITDA margin improving significantly to 14.6% from 7.7% in the year-ago quarter. As per The Hindu BusinessLine, consolidated revenue from operations reached ₹756 crore on a reported basis and ₹785 crore on a like-for-like basis, up about 32% year-on-year. Volume growth was 30.5% YoY, while EBITDA rose ~2.5x YoY to ₹1.1 billion with margins at 14.1%. According to The Hindu BusinessLine, shares touched a 52-week high of ₹501.60 on the NSE on Friday, August 14, before losing at ₹502.80, up 4.87%, with over 2.24 crore shares changing hands worth roughly ₹1,114 crore for the session.
As reported by The Economic Times, Honasa Consumer's focus categories demonstrated robust growth of over 35%, supported by strong performance across key channels. Mamaearth accelerated to high-teens growth, led by its focus categories, with Rice Dewy Bright becoming the brand's number one face cleanser. Rosemary became the second hair ingredient to cross ₹100 crore annualized revenue run rate after Onion. The Derma Co. reached ₹1,000 crore net sales value ARR and entered the Teens EBITDA Club, with its face cleansers crossing ₹200 crore ARR. The company highlighted that it is the only FMCG company in India to build two ₹1,000 crore brands in the last 10 years. According to The Hindu BusinessLine, the company's younger brands, including The Derma Co, Aqualogica, Dr. Sheth's, BBlunt, Staze and newly acquired Reginald Men, grew collectively at 40%. As per The Hindu BusinessLine, The Derma Co crossed an annualised revenue run rate of ₹1,000 crore. According to CNBC TV18, Emkay Global noted that Mamaearth delivered high-teens growth and The Derma Co brand crossed ₹1,000 crore annualized revenue (ARR) with teen margins, while other products continued growing at a "breathtaking pace." As per The Hindu BusinessLine, JM Financial pointed to Mamaearth's acceleration to high-teens sales growth in the quarter, up from mid-teens in Q4 FY26, as a key positive. JM Financial revised its FY27–29 earnings estimates upward by 15 to 19%, with management expecting overall revenue growth in FY27 to exceed the company's five-year high-teens CAGR guidance.
According to The Economic Times, the company's younger brands demonstrated exceptional growth of over 40%, supported by traction across Gen Z innovation, premium serums, men's skincare, hair colour and sunscreen. BTM Ventures crossed ₹150 crore ARR and has grown more than twofold since its acquisition, expanding beyond its South India stronghold into Maharashtra, newer channels and categories. The Derma Co. reached ₹1,000 crore annualized net sales value run rate, while brand searches rose 34% year-on-year to record levels. Face cleansers crossed ₹200 crore annualized run rate, taking the number of categories above that threshold to three, alongside serums and sunscreens. The company's offline business continued to scale significantly, with both General Trade and Modern Trade growing over 40%, while outlet coverage crossed approximately 3 lakh FMCG retail outlets. Additionally, Honasa Consumer entered the fragrance category with FIKN, described as India's first elixir brand, targeting a large and underpenetrated category in India. As per The Hindu BusinessLine, General trade and modern trade both grew over 40%, while eCommerce grew over 20% during the quarter. According to CNBC TV18, Jefferies noted that Honasa continues to build what management describes as a "House of Brands", reducing dependence on any single franchise.
As reported by The Economic Times, Honasa Consumer is simultaneously broadening its category footprint with FIKN marking its entry into fragrance, positioning it as India's first elixir brand targeting men aged 20-35 in metros and tier 1 cities. "Fragrance is one of the largest beauty categories globally and India's fastest-growing beauty category, estimating the Indian perfume market at more than ₹7,000 crore in 2026 and a 15% CAGR," said CEO Varun Alagh. The company's focus categories now account for more than 85% of its business, up 450 basis points year-on-year, while e-commerce grew more than 20% during the quarter. Co-founder Ghazal Alagh emphasized that "We keep looking at trends and experimenting, but we are sure we want to stick to our focus categories for now. Unless proven, we don't want to invest big amounts of money." According to CNBC TV18, Jefferies expects offline expansion, gains in focus-category share and new bets in wellness and fragrance to support management's growth and margin roadmap. As per The Hindu BusinessLine, HDFC Securities noted that the company's adjusted EBITDA margin of around 13 per cent beat their estimate of 12.5 per cent, supported by better channel mix and seasonal tailwinds. HDFC Securities expects high-teen revenue growth and sub-30 per cent earnings CAGR over FY26–29.
As reported by Business Standard, Honasa Consumer stock hit a 52-week high of ₹501.55, surging 5% on Friday's intra-day deals after reporting healthy Q1FY27 earnings. The stock surpassed its previous high of ₹491 touched on July 14, 2026 and has more-than-doubled or zoomed 102% from its 52-week low of ₹248.55 touched on December 11, 2025. At 09:30 AM, Honasa Consumer quoted 3% higher at ₹494.75, as compared to 0.44% decline in the BSE Sensex. The average trading volume at the counter jumped over 15-fold, with a combined 6.7 million equity shares changing hands on the NSE and BSE. According to The Hindu BusinessLine, shares of Honasa Consumer touched a 52-week high of ₹501.60 on the NSE on Friday, August 14, before losing at ₹502.80, up 4.87%, with over 2.24 crore shares changing hands worth roughly ₹1,114 crore for the session. The total market capitalisation stood at approximately ₹16,366 crore at close. The sell side order book on NSE showed about 72 per cent on the sell side versus 28 per cent on the buy side mid-session, reflecting some profit-booking near the 52-week high. The stock carries a P/E of around 62.7 times. According to The Hindu BusinessLine, HDFC Securities maintained a BUY rating with a June 2027 target price of ₹550, while JM Financial raised its target price to ₹560 from ₹485 earlier, citing strong Q1 performance and an upbeat outlook. Mayank Jain, Market Analyst at Share.Market by PhonePe, noted that while the technical trend remains firmly bullish, with the stock trading above its 20-day, 50-day and 200-day moving averages at ₹461, ₹448 and ₹339 respectively, prospective buyers may benefit from waiting for a consolidation or minor pullback toward those support levels before taking fresh positions. The stock has returned approximately 75 per cent over the past year against Nifty 500's gain of around 4 per cent in the same period. ICICI Securities has now raised its target price to ₹720 from ₹600 earlier, reiterating a BUY rating and maintaining Honasa as their preferred pick in the consumer space.